CIK 0001213037 · Non-accelerated filer<br>Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 272004382
- Phone
- 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-27 | Armitage James O Director | Grant or award · Stock Options | +29,700 | 146,974 | ||
| 2024-06-27 | Markin Rodney S Director | Grant or award · Stock Options | +29,700 | 182,027 | ||
| 2024-03-07 | Levine James E. Chief Financial Officer | Grant or award · Stock Options | +205,008 | 962,496 | ||
| 2024-03-07 | Kabbinavar Fairooz Chief Medical Officer | Grant or award · Stock Options | +205,008 | 630,008 | ||
| 2024-03-07 | Smeal Tod Chief Scientific Officer | Grant or award · Stock Options | +205,008 | 647,184 | ||
| 2024-03-07 | Erlander Mark Chief Executive Officer | Grant or award · Stock Options | +510,000 | 2,170,310 | ||
| 2023-12-19 | PACE GARY W Director | Purchase | +30,000 | $1.37 | $41K | 697,761 |
| 2023-11-10 | PACE GARY W Director | Purchase | +22,950 | $0.98 | $22K | 667,761 |
| 2023-06-15 | Markin Rodney S Director | Grant or award · Stock Options | +27,700 | 152,327 | ||
| 2023-06-15 | Armitage James O Director | Grant or award · Stock Options | +27,700 | 117,274 | ||
| 2023-06-15 | White Lale Director | Grant or award · Stock Options | +27,700 | 117,274 | ||
| 2023-06-15 | PACE GARY W Director | Grant or award · Stock Options | +27,700 | 117,274 | ||
| 2023-06-15 | Mohindru Mani Director | Grant or award · Stock Options | +27,700 | 98,501 | ||
| 2023-06-15 | TANNENBAUM RENEE P Director | Grant or award · Stock Options | +27,700 | 98,501 | ||
| 2023-03-15 | Smeal Tod Chief Scientific Officer | Grant or award · Stock Options | +167,088 | 442,176 | ||
| 2023-03-15 | Levine James E. Chief Financial Officer | Grant or award · Stock Options | +197,472 | 757,488 | ||
| 2023-03-15 | Kelemen Vicki Exec. VP and COO | Grant or award · Stock Options | +125,520 | 698,304 | ||
| 2023-03-15 | Erlander Mark Chief Executive Officer | Grant or award · Stock Options | +482,064 | 1,664,477 | ||
| 2022-11-25 | Erlander Mark Chief Executive Officer | Purchase | +10,000 | $1.43 | $14K | 24,481 |
| 2022-09-19 | White Lale Director | Purchase | +15,000 | $1.64 | $25K | 113,788 |
Page 3 of 8 · 144 trades